Literature DB >> 18208564

Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment.

Stephanie Weibel1, Jochen Stritzker, Matthias Eck, Werner Goebel, Aladar A Szalay.   

Abstract

The successful application of live bacteria in cancer therapy requires a more detailed understanding of bacterial interaction with the tumour microenvironment. Here, we analysed the effect of Escherichia coli K-12 colonization on the tumour microenvironment by immunohistochemistry and fluorescence microscopy in the murine 4T1 breast carcinoma model. We described the colonization of tumour-bearing mice, as well as the spatiotemporal distribution of E. coli K-12 in the 4T1 tumour tissue over a period of 14 days. The colonization resulted within 3 days in large avascular necrotic tissue, redistribution of hypoxic areas and an enhanced collagen IV deposition within the colonized tumour tissue, which changed the tumoral perfusion of systemically injected immunoglobulins. In addition, E. coli K-12 colonization led to the redistribution of tumour-associated macrophages, forming a granulation tissue around bacterial colonies, and also to an increase in TNFalpha and matrix metalloproteinase 9 expression. Colonization of 4T1 tumours by E. coli K-12 resulted in strong reduction of pulmonary metastatic events. These new insights will contribute to the general understanding of the tumour-microbe cross-talk and to the design of bacterial strains with enhanced anticancer efficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18208564     DOI: 10.1111/j.1462-5822.2008.01122.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  42 in total

1.  A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy.

Authors:  Kelly Flentie; Brandon Kocher; Seth T Gammon; Deborah V Novack; Jeffrey S McKinney; David Piwnica-Worms
Journal:  Cancer Discov       Date:  2012-05-03       Impact factor: 39.397

Review 2.  Tumour-targeting bacteria engineered to fight cancer.

Authors:  Shibin Zhou; Claudia Gravekamp; David Bermudes; Ke Liu
Journal:  Nat Rev Cancer       Date:  2018-12       Impact factor: 60.716

Review 3.  Salmonella-allies in the fight against cancer.

Authors:  Sara Leschner; Siegfried Weiss
Journal:  J Mol Med (Berl)       Date:  2010-06-05       Impact factor: 4.599

4.  Characterization and evaluation of a new oncolytic vaccinia virus strain LIVP6.1.1 for canine cancer therapy.

Authors:  Ivaylo Gentschev; Sandeep S Patil; Marion Adelfinger; Stephanie Weibel; Ulrike Geissinger; Alexa Frentzen; Nanhai G Chen; Yong A Yu; Qian Zhang; Gregory Ogilvie; Aladar A Szalay
Journal:  Bioengineered       Date:  2012-10-23       Impact factor: 3.269

5.  Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy.

Authors:  Sheng-Nan Jiang; Thuy X Phan; Taek-Keun Nam; Vu H Nguyen; Hyung-Seok Kim; Hee-Seung Bom; Hyon E Choy; Yeongjin Hong; Jung-Joon Min
Journal:  Mol Ther       Date:  2010-01-05       Impact factor: 11.454

6.  Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68.

Authors:  Ivaylo Gentschev; Ulrike Donat; Elisabeth Hofmann; Stephanie Weibel; Marion Adelfinger; Viktoria Raab; Martin Heisig; Nanhai Chen; Yong A Yu; Jochen Stritzker; Aladar A Szalay
Journal:  J Biomed Biotechnol       Date:  2010-04-01

7.  Shigella mediated depletion of macrophages in a murine breast cancer model is associated with tumor regression.

Authors:  Katharina Galmbacher; Martin Heisig; Christian Hotz; Joerg Wischhusen; Antoine Galmiche; Birgit Bergmann; Ivaylo Gentschev; Werner Goebel; Ulf R Rapp; Joachim Fensterle
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

8.  Significant Growth Inhibition of Canine Mammary Carcinoma Xenografts following Treatment with Oncolytic Vaccinia Virus GLV-1h68.

Authors:  Ivaylo Gentschev; Klaas Ehrig; Ulrike Donat; Michael Hess; Stephan Rudolph; Nanhai Chen; Yong A Yu; Qian Zhang; Jörn Bullerdiek; Ingo Nolte; Jochen Stritzker; Aladar A Szalay
Journal:  J Oncol       Date:  2010-06-23       Impact factor: 4.375

Review 9.  Bacterial therapies: completing the cancer treatment toolbox.

Authors:  Adam T St Jean; Miaomin Zhang; Neil S Forbes
Journal:  Curr Opin Biotechnol       Date:  2008-09-18       Impact factor: 9.740

10.  Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy.

Authors:  Andrea Worschech; Nanhai Chen; Yong A Yu; Qian Zhang; Zoltan Pos; Stephanie Weibel; Viktoria Raab; Marianna Sabatino; Alessandro Monaco; Hui Liu; Vladia Monsurró; R Mark Buller; David F Stroncek; Ena Wang; Aladar A Szalay; Francesco M Marincola
Journal:  BMC Genomics       Date:  2009-07-07       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.